Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Interest Expenses (2018 - 2025)

AVITA Medical's Interest Expenses history spans 8 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 3.7% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $5.0 million, down 6.66%, while the annual FY2025 figure was $5.0 million, 6.66% down from the prior year.
  • Interest Expenses reached $1.2 million in Q4 2025 per RCEL's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.4 million in Q3 2024 to a low of $3000.0 in Q1 2021.
  • Average Interest Expenses over 5 years is $641277.8, with a median of $566000.0 recorded in 2023.
  • Peak YoY movement for Interest Expenses: crashed 55.56% in 2022, then soared 33800.0% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $9000.0 in 2021, then tumbled by 33.33% to $6000.0 in 2022, then soared by 18600.0% to $1.1 million in 2023, then increased by 15.69% to $1.3 million in 2024, then dropped by 3.7% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Interest Expenses are $1.2 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025).